Clinical trials: Metformin Adverse Reaction
Diabetes Mellitus, Type 2, Metformin Adverse Reaction
Probiotics in Metformin Intolerant Patients With Type 2 Diabetes
Metformin, the first-line drug in the treatment of type 2 diabetes (T2DM), may cause dose dependent undesirable side-effects like diarrhea, abdominal pain, nausea or bloating which may affect up to 20 % of patients treated with…
- Trial name
- ProGasMet (NCT04089280)
- Testing
- Sanprobi Barrier-multispecies probiotic
- Where
- Poland
- Volunteers
- 37 people
- Sponsor
- Medical University of Silesia
Metformin Adverse Reaction, Tolerance
Trial of an Intervention to Improve Metformin Persistence and Adherence
Metformin is a safe and effective first-line drug for type 2 diabetes that is also widely recommended for weight loss and diabetes prevention.
- Trial name
- TreatMet (NCT03467763)
- Testing
- Metformin Extended Release Oral Tablet
- Where
- United States
- Volunteers
- 13 people, healthy volunteers welcome
- Sponsor
- Weill Medical College of Cornell University
Diabetes Mellitus, Type 2, Metformin Adverse Reaction
Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I
Metformin is associated with a high degree of gastrointestinal intolerance, which limits the effective use of the medication. It is proposed to be an inhibitor of liver mitochondrial glycerophosphate dehydrogenase which results…
- Trial name
- NCT03445702
- Testing
- Metformin
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- St. Louis University
Acute Coronary Syndrome, Unstable Angina
Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
This pilot randomized controlled trial aims to evaluate the feasibility for safety examination of continued metformin therapy in patients with type 2 diabetes (T2D) following invasive coronary angiography.
- Conditions
- Acute Coronary Syndrome, Unstable Angina, Diabetes Mellitus, Metformin Adverse Reaction
- Trial name
- NCT03980990
- Testing
- Metformin
- Where
- Canada
- Volunteers
- 500 people
- Sponsor
- University of Saskatchewan
Diabetes Mellitus, Type 2, Metformin Adverse Reaction
Pharmacokinetics of Metformin Intolerance
Pharmacokinetic study of metformin intolerance
- Trial name
- POMI (NCT03361878)
- Testing
- Metformin Hydrochloride
- Volunteers
- 20 people
- Sponsor
- NHS Tayside